FIELD: medicine.
SUBSTANCE: method involves measuring daily estrone, estradiol and estriol excretion in women of reproductive age. Relation between estriol excretion and total amount of estrone and estradiol excretion after treatment and at control examination stage is calculated. The value being found to grow, relapse is predicted to occur in 11-12 months after the treatment.
EFFECT: high accuracy of prognosis; enhanced effectiveness of treatment.
1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING RELAPSE OF MAMMARY CANCER | 2003 |
|
RU2263319C2 |
METHOD FOR PREDICTION OF CLINICAL COURSE IN DISSEMINATED SKIN MELANOMA PATIENTS | 2008 |
|
RU2399057C1 |
METHOD FOR PREDICTING THE DURATION OF RELAPSE-FREE PERIOD IN PATIENTS WITH MAMMARY CANCER | 2003 |
|
RU2251692C2 |
METHOD OF ESTIMATING EFFICIENCY OF NEOADJUVANT AUTOHEMOCHEMOTHERAPY IN PATIENTS SUFFERING FROM CARCINOMA OF CERVIVAL STUMP | 2008 |
|
RU2375063C1 |
METHOD OF PREDICTING DURATION OF RECURRENCE-FREE PERIOD IN RADICALLY TREATED PATIENTS WITH MAMMARY GLAND CANCER | 2009 |
|
RU2413231C2 |
METHOD OF PROGNOSIS OF DISEASE COURSE IN PATIENTS WITH UTERINE BODY CANCER | 2008 |
|
RU2395097C1 |
METHOD FOR MALIGNANT TUMOUR DISEASE RECURRENCE PREDICTION | 2015 |
|
RU2620306C2 |
METHOD FOR PREDICTION OF EFFECTIVENESS OF NEOADJUVANT AUTOMYELOCHEMOTHERAPY IN PATIENTS WITH RECURRENT BREAST CANCER | 2008 |
|
RU2393484C1 |
METHOD OF PROVIDED EFFICIENCY OF NON-ADJUVANT AUTOHEMOCHEMOTHERAPY FOR PATIENTS SUFFERING FROM PAGET-TYPE BREAST CANCER | 2007 |
|
RU2328747C1 |
METHOD FOR PREDICTION OF CERVICAL CANCER METASTASES | 2010 |
|
RU2436102C1 |
Authors
Dates
2006-04-27—Published
2004-03-15—Filed